Cargando…
The molecular pathophysiology of depression and the new therapeutics
Major depressive disorder (MDD) is a highly prevalent and disabling disorder. Despite the many hypotheses proposed to understand the molecular pathophysiology of depression, it is still unclear. Current treatments for depression are inadequate for many individuals, because of limited effectiveness,...
Autores principales: | Tian, Haihua, Hu, Zhenyu, Xu, Jia, Wang, Chuang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9301929/ https://www.ncbi.nlm.nih.gov/pubmed/35875370 http://dx.doi.org/10.1002/mco2.156 |
Ejemplares similares
-
The Therapeutic Potential of tRNA-derived Small RNAs in Neurodegenerative Disorders
por: Tian, Haihua, et al.
Publicado: (2022) -
The PPARg System in Major Depression: Pathophysiologic and Therapeutic Implications
por: Gold, Philip W.
Publicado: (2021) -
Genetic Insights into the Molecular Pathophysiology of Depression in Parkinson’s Disease
por: Angelopoulou, Efthalia, et al.
Publicado: (2023) -
In Search of New Therapeutics—Molecular Aspects of the PCOS Pathophysiology: Genetics, Hormones, Metabolism and Beyond
por: Wawrzkiewicz-Jałowiecka, Agata, et al.
Publicado: (2020) -
Pathophysiology and Emerging Molecular Therapeutic Targets in Heterotopic Ossification
por: Felix-Ilemhenbhio, Favour, et al.
Publicado: (2022)